Position in ABBV
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,490,463
+$202,270 QoQ
Shares Held
5,923
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#2,180
of 4,153 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 91%
Shared 8%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank & Trust Co holds $22,231,590 across 12 Drug Manufacturers - General names. ABBV ranks #4 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,001 | $13,194,930 | |
| 2 | JNJ |
Johnson & Johnson
|
10,126 | $2,571,700 | |
| 3 | MRK |
Merck & Co., Inc.
|
14,439 | $1,855,411 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
5,923 | $1,490,463 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,387 | $1,174,698 | |
| 6 | PFE |
Pfizer Inc
|
40,931 | $985,618 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,090 | $769,410 | |
| 8 | GSK |
GSK plc
|
1,879 | $98,497 |
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,490,463 | 5,923 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $1,288,193 | 5,923 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,353,346 | 5,923 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $1,371,411 | 5,923 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $1,099,427 | 5,923 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,224,015 | 5,842 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,052,339 | 5,922 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $1,169,476 | 5,922 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $1,015,741 | 5,922 | Shares | Sole | 2024-07-08 | |
| No filing history on record for this holder in this stock. | ||||||